We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.31%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$111B
AUM Growth
+$1.46B
Cap. Flow
+$2.6B
Cap. Flow %
2.33%
Top 10 Hldgs %
23.97%
Holding
4,345
New
253
Increased
2,150
Reduced
1,535
Closed
239

Sector Composition

Rank Sector Weight
1 Technology 14.74%
2 Financials 9%
3 Healthcare 8.22%
4 Consumer Discretionary 6.53%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBEV
3826
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$91K ﹤0.01%
65,597
+2,674
+4% +$4.87K
PGEN icon
3827
Precigen
PGEN
$2.46B
$90K ﹤0.01%
18,059
+850
+5% +$4.89K
APRN
3828
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$90K ﹤0.01%
+1,017
New +$53.5K
IZEA icon
3829
IZEA Worldwide
IZEA
$62.5M
$89K ﹤0.01%
11,535
PUMP icon
3830
ProPetro Holding
PUMP
$1.43B
$89K ﹤0.01%
+10,253
New +$80.1K
ROOT icon
3831
Root
ROOT
$799M
$89K ﹤0.01%
939
-1,022
-52% -$127K
ACIC icon
3832
American Coastal Insurance
ACIC
$464M
$87K ﹤0.01%
23,940
-107,273
-82% -$431K
TGB
3833
Trekor Metals
TGB
$3.23B
$87K ﹤0.01%
46,243
-11,863
-20% -$21.3K
STON
3834
DELISTED
StoneMor Inc.
STON
$87K ﹤0.01%
35,372
CTAC.U
3835
DELISTED
Cerberus Telecom Acquisition Corp. Units, each consisting of one Class A ordinary share and one-thir
CTAC.U
$87K ﹤0.01%
10,605
FINS.RT
3836
DELISTED
Angel Oak Financial Strategies Income Term Trust Rights (expires October 14, 2021)
FINS.RT
$86K ﹤0.01%
+400,815
New +$98K
FUND
3837
Sprott Focus Trust
FUND
$319M
$85K ﹤0.01%
10,300
-25,770
-71% -$214K
IQ icon
3838
iQIYI
IQ
$1.3B
$85K ﹤0.01%
10,540
-9,000
-46% -$93.3K
TECX
3839
Tectonic Therapeutic
TECX
$623M
$85K ﹤0.01%
+1,266
New +$104K
CNVY
3840
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
$85K ﹤0.01%
+10,100
New +$89.9K
GSAT icon
3841
Globalstar
GSAT
$10.8B
$84K ﹤0.01%
3,335
-3,132
-48% -$76.8K
MIN
3842
Aberdeen Intermediate Income Fund
MIN
$280M
$84K ﹤0.01%
23,204
-1,672
-7% -$6.18K
ACB
3843
Aurora Cannabis
ACB
$216M
$83K ﹤0.01%
1,200
-415
-26% -$29.5K
LITS
3844
Lite Strategy Inc
LITS
$30.7M
$83K ﹤0.01%
1,496
DAL icon
3845
CALL
Delta Air Lines
DAL
$59.5B
$82K ﹤0.01%
+25,700
New +$1.05M
TMDI
3846
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$81K ﹤0.01%
53,243
+2,000
+4% +$3.25K
RMO
3847
PUT
DELISTED
Romeo Power, Inc.
RMO
$81K ﹤0.01%
10,500
DNN icon
3848
Denison Mines
DNN
$3B
$80K ﹤0.01%
55,140
-1,000
-2% -$1.21K
TDS icon
3849
CALL
Telephone and Data Systems
TDS
$3.84B
$80K ﹤0.01%
88,600
-2,900
-3% -$60.2K
EPM icon
3850
Evolution Petroleum
EPM
$135M
$79K ﹤0.01%
13,842
-51
-0.4% -$228

Similar funds

Raymond James & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Raymond James & Associates held 4,345 positions worth $111B, up 1.3% from $110B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2021 filing shows 253 new, 2,150 increased, 1,535 reduced and 239 closed positions. Its largest new stake was GXO Logistics: 224,392 shares worth $17.6M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $358M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2021 buy was GXO Logistics: 224,392 shares worth $17.6M.
  • Raymond James & Associates added most to Vanguard Morningstar Mid-Cap ETF in Q3 2021, an estimated $569M increase.
  • Raymond James & Associates's biggest Q3 2021 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $358M.
  • Raymond James & Associates fully exited Invesco S&P 500 Equal Weight Energy ETF in Q3 2021, selling an estimated $9.16M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $111B portfolio in Q3 2021.
  • Raymond James & Associates opened 253 new positions and closed 239 in Q3 2021.
  • Raymond James & Associates's portfolio value rose 1.3% quarter-over-quarter to $111B.

Based on Raymond James & Associates's 13F filing for Q3 2021, filed 2 Nov 2021.